Patent · US Active

Process for preparation of polymorphic form of Mirabegron

US9981927B2 · kind B2 · utility

0Cited by
4References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 2, 2016
Grant dateMay 29, 2018
Priority date
Expiry dateFeb 2, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to process for preparation of α-form crystal of Mirabegron, (R)-2-(2-aminothiazol-4-yl)-N-(4-(2-((2-hydroxy-2-phenylethyl) amino) ethyl) phenyl) acetamide of formula (1).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.